相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naive or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections
Edward J. Gane et al.
GASTROENTEROLOGY (2016)
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
M. P. Curry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
G. R. Foster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
J. J. Feld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: A Flood of Opportunity''
E. J. Gane et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients
Angelo Sangiovanni et al.
HEPATOLOGY (2006)
Estimating progression to cirrhosis in chronic hepatitis C virus infection
AJ Freeman et al.
HEPATOLOGY (2001)
分享论文
